$AVDL News Article - Avadel Pharmaceuticals Announ
Post# of 26709
(Total Views: 107)
Posted On: 05/01/2023 1:25:46 PM
$AVDL News Article - Avadel Pharmaceuticals Announces Final FDA Approval of LUMRYZ(TM) (sodium oxybate) for Extended-Release Oral Suspension as the First and Only Once-at-Bedtime Oxybate for Cataplexy or Excessive Daytime Sleepiness in Adults with Narcolepsy https://marketwirenews.com/news-releases/avad...61759.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼